Toxicity is a primary cause of compound attrition at all stages of drug discovery and development. Approximately 70% of all toxicity-related attrition occurs preclinically, and most of these findings ...
Annaly Capital Management Inc. 6.5% Conv. Pfd. Series G 0.44% Annaly Capital Management Inc. Pfd. Series I 0.04% Annaly Capital Management Inc. 6.95% Cum. Redeem. Pfd. Series F 0.98% Go to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback